Spijkerboer, Feline L.
Overdyk, Frank J.
Dahan, Albert
Funding for this research was provided by:
Medtronic
Article History
Received: 10 November 2023
Accepted: 17 March 2024
First Online: 15 April 2024
Declarations
:
: FLS and AD or their institution received financial support from Medtronic in the form of consulting fees to support the current analysis. Further, AD or their institution received consulting fees from Medtronic for serving on the Clinical Events Committee of the original trial, which was sponsored by Medtronic. FJO declares that he has no competing interests.
: Ethics approval was collected for each site that participated in the original PRODIGY trial. All methods were carried out in accordance with relevant guidelines and regulations (Declaration of Helsinki).
: Written informed consent was required before a patient was enrolled in the original PRODIGY trial.
: Not applicable.